Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
Huang LY, Chang CC, Lee YS, Huang JJ, Chuang SH, Chang JM, Kao KJ, Lau GM, Tsai PY, Liu CW, Lin HS, Gish RG, Lau JY.
Huang LY, et al. Among authors: lau gm.
Cancer Chemother Pharmacol. 2014 Sep;74(3):511-20. doi: 10.1007/s00280-014-2540-7. Epub 2014 Jul 20.
Cancer Chemother Pharmacol. 2014.
PMID: 25038613